Johnson & Johnson's shares rose nearly 4% in early trading to hit a near two-month high of $164.48 on Wednesday as the company's $8.9 billion offer to settle talc-related lawsuits gained support of thousands of claimants, easing an overhang on its plans to list consumer health unit Kenvue.